Is $MNPR pump-proof?

Monopar Therapeutics: trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-09-16.

$MNPR
Monopar Therapeutics
CLEAR RISK
19
/ 100 trap score
Price and crowd are quiet right now, but there's dilution machinery on file. Quiet isn't the same as clean; a rally here feeds the share printer.
Hype / crowding
5
Run-up / extension
5
Structural risk
55
$Registered resale supply (424B5, 12 months ago): existing holders cleared to sell their shares into strength [424B5 (resale) 2025-09-24]↗
🔒 2 more filings flagged on $MNPR: see all of them free.
All 3 flags + filing links, free. No spam, unsubscribe anytime.
PumpProof · pumpproof.com
as of 2026-09-16 · not financial advice

The record on $MNPR

first scored Aug 2: -4% since
23Aug 2
19Aug 27
21Aug 31
19Sep 1
19Sep 2
19Sep 4
19Sep 9
19Sep 16
Every score we publish is snapshotted the day it runs. Wins and misses stay on the record. Full ledger in the Friday email.
What these filings mean
What an ATM offering is →What a shelf registration is →How share dilution works →All the filing explainers →
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts: how every score aged, wins and misses. Free, in your inbox.